Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGIN

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Revealed
India's Third Giant Leap

This Could be One of the Biggest Opportunities for Investors




Important: We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
By submitting your email address, you also sign up for Profit Hunter, a daily newsletter from Equitymaster
covering exciting investing ideas and opportunities in India.

AD

Consumer durables fuels Indian markets
Thu, 22 May 01:30 pm

Indian markets continued to scale higher on the back of continuous buying activity among the index heavyweights during the previous two hours of trade. Stocks from the consumer durables and realty space are leading the gainers, while software stocks are trading weak.

The BSE-Sensex is trading up by 205 points and the NSE-Nifty is trading up by 57 points. The BSE Mid Cap index is trading up 2.4% and the BSE Small Cap index is trading up 2.5% today. The rupee is trading at 58.57 to the US dollar.

Indian pharma stocks are trading mixed. Orchid Chemicals and IPCA Labs are trading firm, while Dishman Pharma is trading lower. As per a leading business daily, Sun Pharma has received a warning letter from the USFDA. According to the US drug regulator, the company's initial response on tackling data integrity violation lacks sufficient corrective actions. It may be noted that the regulator has sent an import alert to Sun Pharma's Karkhadi plant in Gujarat for deviation from good manufacturing practices (GMP) norms in manufacturing of APIs (active pharmaceutical ingredients) that go in to the making of medicines. The company is expected to respond to the matter in due course. Notably, Karkhadi plant's contribution to the company's total sales is negligible. However, till the issue is rectified, the regulator is expected to withhold new applications for the US market from this plant. The move comes at a time when Sun Pharma is seeking to merge the troubled drug maker Ranbaxy with itself.

Retailing stocks are trading mixed today. While Provogue and Zodiac Clothing are trading firm, Shopper's Stop is trading weak. As per a financial daily, Titan's youth fashion brand, Fastrack has shelved its plans to expand into newer segments like footwear and apparels. Footwear category has become competitive as several brands have entered into the space of late. Apart from international brands, some apparel makers have also ventured into the footwear category. Not to mention E-commerce that has further added to the competition. The scenario is no different for the apparels segment, which has also become crowded. The company wants to venture into areas where there is relatively less brand presence so as to increase presence and growth. In the previous year, it had entered into helmets where there are fewer brands. This year it instead plans to increase its range of watches and focus on retail. Fastrack plans to add 74 new stores this fiscal taking its strength to 220. Titan is trading up 7% today.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

View all commentaries | Archives

Read the latest Market Commentary


Equitymaster requests your view! Post a comment on "Consumer durables fuels Indian markets". Click here!

  
ABOUT EQUITYMASTER

Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.

PREMIUM PRODUCTS
QUICK LINKS
POPULAR TOPICS
TRENDING TOPICS
FREE NEWSLETTERS
EQUITYMASTER SUPPORTS
  • HelpYourNGO
  • You Tube
  • Linkedin
  • Twitter
  • Telegram
  • Google Play

Copyright © Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited).

Whitelist | Refer | Terms | Privacy | Contact | About | Sitemap

Phone +91-9136015013

Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited) (Research Analyst)
SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.

103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Email: info@equitymaster.com. Website: www.equitymaster.com.
CIN:U74999MH2007PTC175407

Name of the Compliance & Grievance Officer: Ms Sonal Ramachandran
Telephone: +91-22-61434003 | Email: compliance@equitymaster.com

LEGAL DISCLAIMER:
Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.

Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited) (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.